News

Brief SummaryThis study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a…

Trial Purpose and DescriptionThis is a Phase I/II, multi-center, open-label study designed to evaluate the safety, tolerability and efficacy of elranatamab in…

For East Asian adults with transthyretin amyloid cardiomyopathy (ATTR-CM), the approved therapy Amvuttra (vutrisiran) is a safe and effective treatment, with…